Defining the Flow-Limiting Stenosis Noninvasively for Management of Patients With Coronary Artery Disease∗  by Magalhães, Tiago A. & Lima, João A.C.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 7 , N O . 1 , 2 0 1 4
ª 2 0 1 4 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 3 . 0 8 . 0 1 4EDITORIAL COMMENT
Deﬁning the Flow-Limiting
Stenosis Noninvasively for
Management of Patients With
Coronary Artery Disease*Tiago A. Magalhães, MD, João A. C. Lima, MD
Baltimore, Maryland
Coronary artery disease (CAD) has become the number 1
pathological process responsible for disease burden in the
world. Although traditionally the management of CAD was
based on anatomic stenosis, more recently, better outcomes
have been associated with revascularization of ﬂow-limiting
stenoses as opposed to indications on the basis of purely
anatomic obstructions. The reference standard for deﬁning
ischemia-related coronary obstructions relies on the
measurement of fractional ﬂow reserve (FFR) in the cathe-
terization laboratory during adenosine-induced vasodilation.
Indeed, FFR-guided percutaneous coronary intervention
(PCI) has become the standard of care for intermediate
lesions, with a strong body of evidence now accumulated
using this paradigm (1,2).See page 72In the past, the deﬁnition of ﬂow-limiting stenoses was
accomplished by combining the results of nuclear isotope
perfusion studies with invasive coronary angiography per-
formed on the basis of 3-dimensional vessel-perfusion
territory models constructed mentally during or after coro-
nary angiography, at the time of planning the revasculari-
zation procedure. In recent years, noninvasive assessment of
functionally signiﬁcant stenosis by computed tomography
(CT) has become feasible by performing combined CT
angiography and perfusion studies or by using mathematical
models and ﬂuid dynamics applied to coronary CT angi-
ography (cCTA), and this technique was named “FFR-CT.”
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contents of this paper to disclose.modest in a multicenter trial (3), this approach shows
promise, particularly if combined with other methods
recently developed in addition to pure pressure estimation,
such as ﬂow measurements of the large epicardial vessels
made using CT images.
In this issue of JACC: Cardiovascular Interventions, Kim
et al. (4) reported the application of pressure drop estimation
by FFR-CT in 44 patients (48 lesions) to predict differences
in intracoronary pressures before and after stent implanta-
tion (and, therefore, the success of stenting treatment), using
invasive FFR as the reference. They found a good correlation
between FFR and FFR-CT (r ¼ 0.60 and 0.55 before and
after stenting, respectively), and a diagnostic accuracy of 96%
to predict residual ischemia after stenting. The new method
correctly identiﬁed 44 treated lesions with no residual
ischemia after stenting, and also 2 treated lesions with
identiﬁable ischemia by invasive FFR. FFR-CT had only 2
false positives and no false negatives. Additionally, the
investigators did not ﬁnd differences between FFR and
FFR-CT after stenting (0.024 [95% conﬁdence
interval: 0.08 to 0.13]). On the basis of these results, the
authors emphasize that FFR-CT may be helpful for PCI
planning and also for determination of revascularization
strategies.
The data in the previous text provoke the following
considerations: 1) Is FFR-CT indeed a robust noninvasive
technique to identify absence of ischemia after stenting (high
sensitivity); and 2) can we evaluate its performance to
identify presence of ischemia after stenting (speciﬁcity),
given the small number of true positives in the current
analysis (2 FFR 0.8)? Nevertheless, it is important to
mention that this is the ﬁrst study, to our knowledge,
evaluating FFR-CT for identiﬁcation and planning of
percutaneous revascularizations, and we congratulate the in-
vestigators for using it for this original purpose.
From a practical standpoint, the “virtual stenting”
approach seems very attractive, especially when dealing with
complex and sequential stenoses. Considering that different
revascularization strategies can be simulated before the
invasive procedure, in theory, it is possible to determine the
obstruction(s) that lead to ischemia, and also predict the
functional outcome of revascularizing such lesions. Pre-
procedure FFR-CT might not only be convenient, but also
cost effective, and can avoid unnecessary revascularizations
as well.
On the other hand, there are some challenges to be
overcome before making virtual stenting available in the
clinical scenario. The ﬁrst concern is related to the quality of
the cCTA scans, the basis for FFR-CT calculations. The
process involved in computational ﬂuid dynamics requires
a precise 3-dimensional model of the coronary tree, aorta,
and myocardium to determine the pressures along the
downstream circulation; and motion artifacts, presence of
heavy calciﬁcations, and/or poor signal-to-noise ratios can
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80interfere with the contours of the coronary tree and other
structures. According to a recent meta-analysis (5), at least 1
coronary segment was nondiagnostic in 9.5% of the patients
referred to cCTA for suspected CAD (6). In other words,
for any the aforementioned reasons, and others that are less
important in frequency and magnitude, we have a number of
nondiagnostic segments in routine cCTA that can affect the
diagnostic accuracy of FFR-CT. Even though previous data
(7) showed the robustness of this methodology across
different levels of image quality and artifacts, there is a
consensus that an excellent quality scan should be the basis
for a good FFR-CT study.
The second issue that should be addressed to improve this
new approach is to carefully validate it using animal models.
To date, there are no previous experimental studies unravel-
ing the complex interactions between degree of stenosis,
coronary blood ﬂow, and computational ﬂuid dynamics in
stented lesions. As a result, the current methodology lacks
a strong physiopathological foundation. Understanding these
mechanisms will likely lead to consistent improvement in the
noninvasive estimation of coronary blood ﬂow.
Important advances in cardiovascular imaging of recent
years have offered a wide range of tools to determine ischemic
burdendone of the most important surrogate markers of
CAD. Even though FFR is the current gold standard for
identifying ischemia-producing obstructions, we cannot
assess the coronary ﬂow reserve using this technique. Both are
important in the coronary physiology assessment, even being
discordant sometimes because of the nature of the measure-
ments (FFR relates to pressure drops, whereas coronary ﬂow
reserve relates to ﬂow) (8). In this regard, myocardial blood
ﬂow estimations by other modalities are available, including
by positron emission tomography (9), magnetic resonance
(10), and most recently, by CT, using pharmacological stress
(11). In the future, we should use a more physiological basis,
combining pressure estimation by FFR-CT and also
a measure of coronary ﬂow, in the setting of a noninvasive
revascularization procedure planning. If the matter is to use
the “all-in-one” approach, CT methods are in the best
position to provide this information.
About 35 years ago, we entered an era of minimally inva-
sive coronary revascularization procedures after imple-
mentation of PCI (12). During this period, the diagnosis of
obstructed CAD and its hemodynamic signiﬁcance have
been developing fast. Now we have a promising tool to verify
the results of stenting using data from a CT scan. Cardiologyis experiencing a shift from a minimally invasive approach to
virtual-based, clinical decision making. The study by Kim
et al. (4) is an important step in the new direction.
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